We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| -0.25 | -5.15% | 4.60 | 4.50 | 4.70 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 4.85 | 4.60 | 4.85 | 123,819 | 15:06:53 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Biological Pds,ex Diagnstics | 1.83M | -2.24M | -0.0042 | -10.95 | 24.53M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 31/1/2024 | 07:00 | UK RNS | Eden Research plc Board Change |
| 22/1/2024 | 11:42 | ALNC |  Eden Research annual revenue to beat market consensus amid sales boost |
| 22/1/2024 | 07:00 | UKREG | Eden Research plc Trading Update |
| 19/1/2024 | 15:00 | UKREG | Eden Research plc Holding(s) in Company |
| 09/1/2024 | 11:29 | ALNC | Eden Research's Mevalone gains regulatory approval in California |
| 09/1/2024 | 07:01 | UKREG | Eden Research plc Mevalone Approval in the State of California |
| 18/12/2023 | 11:48 | ALNC | Eden Research shares jump as Ecovelex gets approved in Italy |
| 18/12/2023 | 07:00 | UKREG | Eden Research plc Ecovelex(TM)2023 Approval in Italy |
| 28/11/2023 | 07:00 | RNSNON | Eden Research plc Small Cap Virtual Investor Conference |
| 01/11/2023 | 07:00 | UKREG | Eden Research plc Change of Nominated Adviser and Broker |
1 Year Eden Research Chart |
Intraday Eden Research Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
